CoChat

Candidemia in a Tertiary Care Cancer Center: In Vitro Susceptibility and its Association with Outcome of Initial Antifungal Therapy

Antoniadou, Anastasia, Torres, Harrys A., Lewis, Russell E., Thornby, John, Bodey, Gerald P., Tarrand, Jeffrey P., Han, Xiang-Yang, Rolston, Kenneth V. I., Safdar, Amar, Raad, Issam I., Kontoyiannis, Dimitrios P. · 2003 · Medicine
Cited by 131

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

Abstract

Since the 1990s, changing trends have been documented in species distribution and susceptibility to bloodstream infections caused by Candida species in cancer patients. However, few data are available regarding the association between in vitro antifungal susceptibility and outcome of candidemia in this patient population. We therefore evaluated the association of in vitro antifungal susceptibility and other risk factors with failure of initial antifungal therapy in cancer patients with candidemia. Candidemia cases in cancer patients from 1998 to 2001 (n = 144) were analyzed retrospectively along with their in vitro susceptibility to amphotericin B, fluconazole, and itraconazole (National Committee for Clinical and Laboratory Standards M27-A method). Patients were evaluable for outcome analysis if they received continuous unchanged therapy with either fluconazole or amphotericin B for >/=5 days. We excluded cases of mixed candidemia. In vitro susceptibility testing data of the first Candida bloodstream isolate were analyzed. Appropriate therapy was defined as that using an active in vitro antifungal for >/=5 days. For fluconazole susceptible-dose dependent Candida species, we defined appropriate therapy as a fluconazole dose of >/=600 mg/day. The Candida species distribution was 30% Candida albicans, 24% Candida glabrata, 23% Candida parapsilosis, 10% Candida krusei, 9% Candida tropicalis, and 3% other. Overall, amphotericin B was the most active agent in vitro, with only 3% of the isolates exhibiting resistance to it (>1 mg/L). Dose-dependent susceptibility to fluconazole and itraconazole was seen in 13% and 21% of the isolates, respectively, while resistance to fluconazole and itraconazole was seen in 13% and 26%, respectively.Eighty patients were evaluable for outcome analysis. In multivariate analysis, the following factors emerged as independent predictors of failure of initial antifungal therapy: leukemia (p = 0.01), bone marrow transplantation (p = 0.006), and intensive care unit stay at onset of infection (p = 0.02). Inappropriate antifungal therapy, as defined by daily dose and in vitro susceptibility, was not shown consistently to be a significant factor (it was significant in multivariate analysis, p = 0.04, but not in univariate analysis), indicating the complexity of the variables that influence the response to antifungal treatment in cancer patients with candidemia.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/01.md.0000091182.93122.8e

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 14 references

Cited by

See all 131

Metadata

Authors
Antoniadou, A., Torres, H. A., Lewis, R. E., Thornby, J., Bodey, G. P., Tarrand, J. P., Han, X.-Y., Rolston, K. V. I., Safdar, A., Raad, I. I., & Kontoyiannis, D. P.
Venue
Medicine
Published
2003-09
Volume
82
Issue
5
Pages
309-321
ISSN
0025-7974 (ISSN-L)
OpenAlex
W2026729241
Cited by
131
References
14
FWCI
6.12
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Candidemia in a Tertiary Care Cancer Center: In Vitro Susceptibility and its Association with Outcome of Initial Antifungal Therapy. https://app.cochat.ai/papers/10.1097/01.md.0000091182.93122.8e
The paper
Antoniadou, A., Torres, H. A., Lewis, R. E., Thornby, J., Bodey, G. P., Tarrand, J. P., Han, X.-Y., Rolston, K. V. I., Safdar, A., Raad, I. I., & Kontoyiannis, D. P. (2003). Candidemia in a Tertiary Care Cancer Center: In Vitro Susceptibility and its Association with Outcome of Initial Antifungal Therapy. Medicine. https://doi.org/10.1097/01.md.0000091182.93122.8e

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.